DR. MEZGEBE BERHE MD NPI 1831155787

NPI Details

DR. Mezgebe Berhe, MD is an infectious disease internal medicine in Dallas, TX with 32 years of experience. The provider is an internist who deals with infectious diseases of all types and in all organ systems. Conditions requiring selective use of antibiotics call for this special skill. This physician often diagnoses and treats AIDS patients and patients with fevers which have not been explained. Infectious disease specialists may also have expertise in preventive medicine and travel medicine. DR. Mezgebe Berhe, MD NPI is 1831155787. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3409 WORTH ST
710
DALLAS, TX
ZIP 75246-029
Phone: (214) 823-2533
Fax: (214) 824-8679

The NPI 1831155787 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, belatacept, 1 mg (HCPCS:J0485)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, daptomycin, 1 mg (HCPCS:J0878)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older (HCPCS:36573)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 4/20/2006 and was last updated on 10/12/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.